CommentThe tubal hypothesis of ovarian cancer: caution needed
References (10)
- et al.
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies
Am J Hum Genet
(2003) - et al.
Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?
Am J Obstet Gynecol
(2011) - et al.
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality
JAMA
(2010) - et al.
Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers
J Clin Oncol
(2005) - et al.
The distal fallopian tube: a new model for pelvic serous carcinogenesis
Curr Opin Obstet Gynecol
(2007)
Cited by (28)
Promising agents on the horizon
2020, Overcoming Ovarian Cancer ChemoresistanceA salpingeal carcinoma revealed after prophylactic salpingoophorectomy in an asymptomatic BRCA1 carrier with breast malignancy
2018, International Journal of Surgery Case ReportsSalpingectomy and prevention of ovarian carcinoma
2016, Gynecology and Minimally Invasive TherapyCitation Excerpt :As we move forward, new research is still needed to provide insight into the carcinogenesis and interaction between the tubes and ovaries and molecular studies may someday find more effective screening strategies.59,60
Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: A meta-analysis
2016, European Journal of CancerCitation Excerpt :After reading the abstracts, a total of 35 studies were excluded, and 37 were assessed in full-text form. Of the 37 citations evaluated in full-text form, one was a committee opinion,26 three were letters to the editor,27–29 four were comments,30–33 one was a case report,34 three were review articles,35–37 three were articles about surveys,38–40 four reported on BRCA,41–44 seven did not report on salpingectomy (one reported on oophorectomy45 and six reported on tubal ligation46–51), five did not focus on cancer incidence (two reported on ovarian reserves3,52 and three reported on operative complications53–55), and two did not give data for the calculation of OC incidence.56,57 These citations were thus excluded.
Prophylactic salpingectomy or salpingo-oophorectomy as an ovarian cancer prevention?
2015, Presse MedicaleRisk assessment, genetic counseling, and clinical care for hereditary breast cancer
2014, JOGNN - Journal of Obstetric, Gynecologic, and Neonatal NursingCitation Excerpt :There may be a benefit to this approach in that progesterone supplementation appears to raise subsequent breast cancer risk more than estrogen monotherapy when provided to postmenopausal women (de Villiers et al., 2013). Finally, theoretical risk exists for the development of cancer in the remaining stump of fallopian tube imbedded within the wall of the uterus (Collins, Domchek, Huntsman, & Mitchell, 2011). Although each of these issues in isolation may not be enough to guide a woman's decision about oophorectomy or hysterectomy, the additive effect of these potential benefits may influence a woman's choice.